# Citius Pharmaceuticals, Inc.: Form 8-K, filed Jan 8, 2025

- Company: [Citius Pharmaceuticals, Inc.](/companies/ctxr.md) (CIK 1506251)
- Form: 8-K
- Filed: 2025-01-08
- Accepted by EDGAR: Jan 8, 2025, 16:05 ET
- Period: 2025-01-07
- Accession: 0001213900-25-002071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/ea0227130-8k_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/ea0227130-8k_citius.htm

Filed Jan 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-002071. Last ingested by Listed: Nov 4, 2026, 17:46 ET. No prices; not investment advice.